Soluble epoxide hydrolase pharmacological inhibition ameliorates experimental acute pancreatitis in mice

Molecular Pharmacology

Volumn 88, Issue 2, 2015, Pages 281-290

  Bettaieb, Ahmed ^a   Chahed, Samah ^a   Bachaalany, Santana ^a   Griffey, Stephen ^a   Hammock, Bruce D ^a,c   Haj, Fawaz G ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1-TRIFLUOROMETHOXYPHENYL-3-(1-PROPIONYLPIPERIDINE-4-YL)UREA; AMYLASE; ARGININE; CARBANILAMIDE DERIVATIVE; CERULETIDE; EPHX2 PROTEIN, MOUSE; EPOXIDE HYDROLASE; IL1B PROTEIN, MOUSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; PIPERIDINE DERIVATIVE; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MOUSE; PANCREATITIS; SIGNAL TRANSDUCTION;

AMYLASES; ANIMALS; ARGININE; CERULETIDE; DISEASE MODELS, ANIMAL; EPOXIDE HYDROLASES; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPASE; MAP KINASE SIGNALING SYSTEM; MICE; PANCREATITIS; PHENYLUREA COMPOUNDS; PIPERIDINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84939812796     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.097501     Document Type: Article

References (54)

1. Al-Bahrani AZ and Ammori BJ (2005) Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta 362:26-48.
2. Bae GS, Kim MS, Jeong J, Lee HY, Park KC, Koo BS, Kim BJ, Kim TH, Lee SH, and Hwang SY, et al. (2011) Piperine ameliorates the severity of cerulein-induced acute pancreatitis by inhibiting the activation of mitogen activated protein kinases. Biochem Biophys Res Commun 410:382-388.
3. Baumann B, Wagner M, Aleksic T, von Wichert G, Weber CK, Adler G, and Wirth T (2007) Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo. J Clin Invest 117:1502-1513.
4. Bettaieb A, Chahed S, Tabet G, Yang J, Morisseau C, Griffey S, Hammock BD, and Haj FG (2014) Effects of soluble epoxide hydrolase deficiency on acute pancreatitis in mice. PLoS One 9:e113019.
5. Bettaieb A, Nagata N, AbouBechara D, Chahed S, Morisseau C, Hammock BD, and Haj FG (2013) Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue. J Biol Chem 288:14189-14199.
6. Bonizzi G and Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280-288.
7. Ceranowicz P, Cieszkowski J, Warzecha Z, and Dembinski A (2015). Experimental models of acute pancreatitis. Postepy Hig Med Dosw 69:264-269.
8. Chen L, Fan C, Zhang Y, Bakri M, Dong H, Morisseau C, Maddipati KR, Luo P, Wang CY, and Hammock BD, et al. (2013) Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. Prostaglandins Other Lipid Mediat 104-105:42-48.
9. Chen X, Ji B, Han B, Ernst SA, Simeone D, and Logsdon CD (2002) NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 122:448-457.
10. Dawra R, Sharif R, Phillips P, Dudeja V, Dhaulakhandi D, and Saluja AK (2007) Development of a new mouse model of acute pancreatitis induced by administration of L-arginine. Am J Physiol Gastrointest Liver Physiol 292:G1009-G1018.
11. Dembiński A, Warzecha Z, Ceranowicz P, Warzecha AM, Pawlik WW, Dembiński M, Rembiasz K, Sendur P, Kuśnierz-Cabala B, and Tomaszewska R, et al. (2008) Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis: role of sensory nerves. Eur J Pharmacol 591:284-292.
12. Enayetallah AE, French RA, Thibodeau MS, and Grant DF (2004) Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52:447-454.
13. Frossard JL, Rubbia-Brandt L, Wallig MA, Benathan M, Ott T, Morel P, Hadengue A, Suter S, Willecke K, and Chanson M (2003) Severe acute pancreatitis and reduced acinar cell apoptosis in the exocrine pancreas of mice deficient for the Cx32 gene. Gastroenterology 124:481-493.
14. Höfken T, Keller N, Fleischer F, Göke B, and Wagner AC (2000) Map kinase phosphatases (MKP's) are early responsive genes during induction of cerulein hyperstimulation pancreatitis. Biochem Biophys Res Commun 276:680-685.
15. Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900-917.
16. Imig JD and Hammock BD (2009) Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 8:794-805.
17. Imig JD, Zhao X, Capdevila JH, Morisseau C, and Hammock BD (2002) Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39:690-694.
18. Inceoglu B, Schmelzer KR, Morisseau C, Jinks SL, and Hammock BD (2007) Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat 82:42-49.
19. Ji B, Chen XQ, Misek DE, Kuick R, Hanash S, Ernst S, Najarian R, and Logsdon CD (2003) Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator. Physiol Genomics 14:59-72.
20. Kubisch CH, Sans MD, Arumugam T, Ernst SA, Williams JA, and Logsdon CD (2006) Early activation of endoplasmic reticulum stress is associated with arginine-induced acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 291:G238-G245.
21. Kundu S, Roome T, Bhattacharjee A, Carnevale KA, Yakubenko VP, Zhang R, Hwang SH, Hammock BD, and Cathcart MK (2013) Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo. J Lipid Res 54:436-447.
22. Lerch MM and Gorelick FS (2013) Models of acute and chronic pancreatitis. Gastroenterology 144:1180-1193.
23. Liu JY, Lin YP, Qiu H, Morisseau C, Rose TE, Hwang SH, Chiamvimonvat N, and Hammock BD (2013) Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models. Eur J Pharm Sci 48:619-627.
24. Luo P, Chang HH, Zhou Y, Zhang S, Hwang SH, Morisseau C, Wang CY, Inscho EW, Hammock BD, and Wang MH (2010) Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis. J Pharmacol Exp Ther 334:430-438.
25. Luria A, Bettaieb A, Xi Y, Shieh GJ, Liu HC, Inoue H, Tsai HJ, Imig JD, Haj FG, and Hammock BD (2011) Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci USA 108:9038-9043.
26. Malo A, Krüger B, Göke B, and Kubisch CH (2013) 4-Phenylbutyric acid reduces endoplasmic reticulum stress, trypsin activation, and acinar cell apoptosis while increasing secretion in rat pancreatic acini. Pancreas 42:92-101.
27. Minutoli L, Altavilla D, Marini H, Passaniti M, Bitto A, Seminara P, Venuti FS, Famulari C, Macrì A, and Versaci A, et al. (2004) Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis. Life Sci 75:2853-2866.
28. Morin C, Sirois M, Echavé V, Albadine R, and Rousseau E (2010) 17,18-epoxyeicosatetraenoic acid targets PPARg and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase. Am J Respir Cell Mol Biol 43:564-575.
29. Morisseau C and Hammock BD (2013) Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 53:37-58.
30. Naruse S (2003) Molecular pathophysiology of pancreatitis. Intern Med 42:288-289.
31. Newman JW, Morisseau C, and Hammock BD (2005) Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 44:1-51.
32. Pavlidis P, Crichton S, Lemmich Smith J, Morrison D, Atkinson S, Wyncoll D, and Ostermann M (2013) Improved outcome of severe acute pancreatitis in the intensive care unit. Crit Care Res Pract 2013:897107.
33. Pereda J, Sabater L, Aparisi L, Escobar J, Sandoval J, Viña J, López-Rodas G, and Sastre J (2006) Interaction between cytokines and oxidative stress in acute pancreatitis. Curr Med Chem 13:2775-2787.
34. Petrov MS (2010) Therapeutic implications of oxidative stress in acute and chronic pancreatitis. Curr Opin Clin Nutr Metab Care 13:562-568.
35. Roberts SE, Akbari A, Thorne K, Atkinson M, and Evans PA (2013) The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther 38:539-548.
36. Ron D and Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-529.
37. Rose TE, Morisseau C, Liu JY, Inceoglu B, Jones PD, Sanborn JR, and Hammock BD (2010) 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain. J Med Chem 53:7067-7075.
38. Saluja AK, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbauer B, and Steer ML (1997) Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113:304-310.
39. Sato S, Stark HA, Martinez J, Beaven MA, Jensen RT, and Gardner JD (1989) Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Am J Physiol 257:G202-G209.
40. Schäfer C and Williams JA (2000) Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease. J Gastroenterol 35:1-9.
41. Schmelzer KR, Inceoglu B, Kubala L, Kim IH, Jinks SL, Eiserich JP, and Hammock BD (2006) Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103:13646-13651.
42. Seyhun E, Malo A, Schäfer C, Moskaluk CA, Hoffmann RT, Göke B, and Kubisch CH (2011) Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 301:G773-G782.
43. Shen HC and Hammock BD (2012) Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. J Med Chem 55:1789-1808.
44. Spector AA and Norris AW (2007) Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292:C996-C1012.
45. Tsai HJ, Hwang SH, Morisseau C, Yang J, Jones PD, Kasagami T, Kim IH, and Hammock BD (2010) Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs. Eur J Pharm Sci 40:222-238.
46. Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, and Pandol SJ (2001) Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 280:G1197-G1208.
47. Wagner K, Inceoglu B, Gill SS, and Hammock BD (2011) Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction. J Agric Food Chem 59:2816-2824.
48. Willemer S, Elsässer HP, and Adler G (1992) Hormone-induced pancreatitis. Eur Surg Res 24(Suppl 1):29-39.
49. Yadav D and Lowenfels AB (2006) Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas 33:323-330.
50. Yadav D and Lowenfels AB (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 144:1252-1261.
51. Yang F, Tang E, Guan K, and Wang CY (2003) IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 170:5630-5635.
52. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, and Hammock BD, et al. (2000) Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87:992-998.
53. Zhang W, Liao J, Li H, Dong H, Bai H, Yang A, Hammock BD, and Yang GY (2013) Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency. Mol Carcinog 52:726-738.
54. Zhao M, Xue DB, Zheng B, Zhang WH, Pan SH, and Sun B (2007) Induction of apoptosis by artemisinin relieving the severity of inflammation in caerule-ininduced acute pancreatitis. World J Gastroenterol 13:5612-5617.